Key result
Higher discharge SBP is linked to ~21% lower risk in admission-normotensive non-HFrEF patients but higher risk otherwise.
Why the study?
To evaluate whether discharge SBP has different associations with outcomes in non-HFrEF patients with versus without high blood pressure at admission.
Does discharge SBP level affect the risk of cardiovascular death and heart transplantation in non-HFrEF patients hospitalized for decompensated heart failure?
Cohort (n=964)
Does discharge SBP level affect the risk of cardiovascular death and heart transplantation in non-HFrEF patients hospitalized for decompensated heart failure?
The relationship between discharge SBP and adverse outcomes in non-HFrEF patients is U-shaped and depends on admission blood pressure status, with higher discharge SBP correlating with worse outcomes only in those with admission hypertension.
Discharge SBP targets in non-HFrEF may need personalization by admission BP status; leaves open optimal thresholds pending prospective trials.
OBJECTIVE: We hypothesized that discharge SBP had different associations with outcomes in non-HFrEF (left ventricular ejection fraction ≥40%) patients with or without high blood pressure (HBP) at admission. METHODS: Non-HFrEF patients hospitalized for decompensated heart failure were consecutively recruited and were categorized into HBP (admission SBP ≥130 mmHg) group and non-HBP group. The primary outcome was a composite of cardiovascular death and heart transplantation. Multivariate Cox and penalized spline analyses were used to assess the relationships between discharge SBP and outcomes. RESULTS: Nine hundred and sixty-four non-HFrEF patients were enrolled with a median follow-up of 71.8 months. Three hundred and sixty-five (37.9%) patients had HBP. In multivariate Cox analyses, non-HBP patients with higher discharge SBP were associated with a better outcome (per 10 mmHg increased, hazard ratio = 0.788, P = 0.001). However, an opposite relationship between discharge SBP and the primary outcome was observed in HBP group (per 10 mmHg increased, hazard ratio = 1.312, P = 0.002). Results of penalized spline regression models showed that there was a U-shaped association between discharge SBP and outcomes in the total cohort. Compared with 120 mmHg, the risk of the primary outcome increased when discharge SBP was below 99 mmHg in non-HBP group; in HBP group, a worse outcome was observed when discharged SBP was above 145 mmHg. CONCLUSION: Non-HFrEF had a U-shaped association between discharge SBP and adverse events. Such an association was modified by admission HBP. Higher discharge SBP correlated with a worse outcome in non-HFrEF patients with admission HBP, as opposed to patients admitted without HBP.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2020) conducted a cohort in Non-HFrEF decompensated heart failure (n=964). Higher discharge systolic blood pressure (SBP) vs. Lower discharge SBP was evaluated on Composite of cardiovascular death and heart transplantation (HR 0.788, p=0.001). Higher discharge SBP was associated with better outcomes in non-HFrEF patients without admission high blood pressure (HR 0.788, P=0.001), but worse outcomes in those with it (HR 1.312, P=0.002).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: